Phathom Pharmaceuticals, Inc. SEC filings PHAT
Phathom Pharmaceuticals, Inc. has 495 filings in SEC EDGAR's recent list, going back to Jul 26, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| EFFECT | Filing | Nov 17, 2023 | — |
| CORRESP | Letter to the SEC | Nov 15, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| SC TO-I/A | Filing | Jul 17, 2023 | — |
| SC TO-C | Filing | Jun 15, 2023 | — |
| SC TO-I | Filing | Jun 15, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 23, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| EFFECT | Filing | Nov 17, 2020 | — |
| CORRESP | Letter to the SEC | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2020 | — |
| EFFECT | Filing | Oct 24, 2019 | — |
| CERT | 8a cert | Oct 23, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| 8-A12B | Filing | Oct 16, 2019 | — |
| CORRESP | Letter to the SEC | Sep 30, 2019 | — |
| DRSLTR | Filing | Sep 18, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 10, 2019 | — |
| DRSLTR | Filing | Aug 30, 2019 | — |
| DRS/A | Filing | Aug 30, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2019 | — |
| SEC STAFF LETTER | Filing | Aug 13, 2019 | — |
| DRS | Filing | Jul 26, 2019 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1783183
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.